Human papillomavirus vaccines: current status and perspectives
نویسندگان
چکیده
Cervical cancer is the second cause of death from cancer among women worldwide. Long-term infection with the human papillomaviruse (HPV) can lead to malignant anogenital tumors. The HPV oncogenic types 16 and 18 account for approximately 70% of cervical cancer and have received the greatest attention. Two pharmaceutical companies, Merck and GlaxoSmithKline (GSK), have developed commercial versions of prophylactic HPV vaccine. These vaccines are based on the intrinsic ability of the L1 viral capsid protein to self-assemble into virus-like particles. Both of them target HPV16 and HPV18 with excellent safety profile and type-specific protection. However, therapeutic vaccines are designed to treat preexisting HPV infections and have been focused on the viral oncoproteins, E6 and E7. Various types of therapeutic HPV vaccines have been designed; and many of them are currently in clinical trials. So far, combined approaches appear to be more promising for treating persistent HPV infections. The aim of this review is to summarize the status of HPV vaccines and their perspectives.
منابع مشابه
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells
Introduction: Human papillomavirus (HPV) is the main causative agent of cervical cancer worldwide leading to a big health problem, especially in the developing countries. Among 14 common high-risk genotypes, HPV16 accounts for more than 50% of all cervical cancers. The current prophylactic vaccines against HPV infection are based on L1 protein. Due to some drawbacks in the current vaccines such...
متن کاملCurrent status of human papillomavirus vaccines
Cervical cancer is a malignant neoplasm arising from cells that originate in the cervix uteri. It is the second most prevalent cancer among women. It can have several causes; an infection with some type of human papillomavirus (HPV) is the greatest risk factor for cervical cancer. Over 100 types of HPVs have been identified, and more than 40 types of HPVs are typically transmitted through sexua...
متن کاملCurrent and Next-generation Vaccines against Human Papillomaviruses
Human papillomaviruses (HPVs) infect the squamous epithelium, and cause skin warts, genital warts and cancers, including uterine cervical cancer. Amongst the enormously diverse types of HPVs, HPV16 and HPV18 are most prevalent and responsible for approximately 70% of cervical cancer cases. Current preventive HPV vaccines contain virus-like particles which are composed of L1 major capsid protein...
متن کاملVaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives.
UNLABELLED Background Men and women with HIV infection are at increased risk of developing cancers associated with human papillomavirus (HPV). The two licensed prophylactic HPV vaccines protect against de novo infection with HPV-16 and HPV-18, which cause the majority of HPV-associated cancers. Currently, no vaccine efficacy data are available for persons with HIV infection. Nevertheless, some ...
متن کاملChallenges and Perspectives toward Development of more Effective Influenza Vaccine
Influenza viruses continue to be a major health threat in human and bird populations. The improvements in formulation and production level of the current influenza vaccines are not sufficient to afford complete protection. The continuous antigenic drifts and emergence of endemic and zoonotic strains make influenza vaccine planning difficult. Concern about the emergence of new influenza pandemic...
متن کامل